The oncogenic role of TERT is further supported by findings in uveal melanoma, where activating promoter mutations have been identified in primary tumor samples, reinforcing its importance in melanoma pathogenesis through telomerase reactivation and cellular immortality [84]. This evidence concerns the gene TERT and melanoma.